Zimmer Biomet Holdings Inc. on Wednesday reported third-quarter earnings of $231 million, or $1.16 per diluted common share, a 7% dip from the $249 million, or $1.23 a share, posted for the same three months of 2024.

The Warsaw-based orthopedic devices maker also reported net sales of $2.00 billion, an almost 10% increase from the $1.82 billion posted for the quarter ended Sept. 30 of last year.

Among the additional expenses that contributed to the $18.2 million decline in earnings was a $102 million increase – to $811 million – in selling, general and administrative expenses. That budget line includes marketing, advertising, rent, utilities, distribution costs, sales staff commissions, and executive salaries and benefits.

Ivan Tornos, the company's chairman, president and CEO, said the

See Full Page